Evidera
Kim Doolan-Jennings has an extensive background in managing clinical trials, beginning their career at UCONN Health Center in 1986 as a Clinical Research Associate. Kim has since progressed to roles such as Manager of the Clinical Trials Unit at CT Children's Medical Center and their current positions as Senior Project Manager at Evidera and Director of Site Network and Education at the Institute for Advanced Clinical Trials for Children (I-ACT for Children). Kim is skilled in developing and implementing programs to ensure compliance with regulations and enhancing the growth of pediatric clinical research.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.